Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),General Medicine
Reference49 articles.
1. Edvinsson L, Haanes KA, Warfvinge K, Krause DN. CGRP as the target of new migraine therapies - successful translation from bench to clinic. Nat Rev Neurol. 2018;14(6):338–50.
2. Cutrer MF, Bajwa ZH. Pathophysiology, clinical manifestations, and diagnosis of migraine in adults. In: Swanson JW, Dashe JF, editors. UpToDate. Nov 17, 2018. https://www.uptodate.com/contents/pathophysiology-clinical-manifestations-and-diagnosis-of-migraine-in-adults. Accessed 22 May 2019.
3. GBD 2016 Disease and Injury Incidence and Prevalence Collaborators. Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet. 2017;390(10100):1211–59.
4. American Headache Society. The American Headache Society position statement on integrating new migraine treatments into clinical practice. Headache. 2019;59(1):1–18.
5. Mayans L, Walling A. Acute migraine headache: treatment strategies. Am Fam Phys. 2018;97(4):243–51.
Cited by
8 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献